Japan's October CPI Growth Hits Fastest This Year, Strengthening Expectations for Bank of Japan Rate Hike in December
Japan's CPI growth has reached a new high for the year, supporting expectations for an interest rate hike by the Bank of Japan.
According to Zhitong Finance APP, Japan’s consumer price growth accelerated to its fastest pace this year in October, further solidifying the case for the Bank of Japan to raise its benchmark interest rate next month. Data released by the Ministry of Internal Affairs and Communications on Friday showed that the consumer price index (CPI), excluding fresh food, rose for the second consecutive month, up 2.2% year-on-year—the largest increase since December last year, though still slightly below economists’ median forecast of 2.3%. The core-core CPI—excluding both fresh food and energy, the underlying inflation indicator closely watched by the Bank of Japan—also rose 2.2%; overall CPI increased by 2.3%.

The latest monthly rise was mainly driven by energy costs: overall energy prices rose 2.2% year-on-year, reversing the decline seen in September; mobile-related fees accelerated from 10.9% to 17.2%, also pushing up the overall index. Policymakers are increasingly concerned about the upside risks posed by rising energy costs, persistent yen weakness, and higher semiconductor prices amid the AI boom.
Bank of Japan Shifts Policy Target: From “Pushing Up” to “Anchoring”
Friday’s data strongly supports a benchmark rate hike at the Bank of Japan’s December meeting. The Bank of Japan has clearly indicated that its policy goal is no longer to push underlying inflation toward the 2% target, but to anchor it stably around that level. At last month’s meeting (October 30), the central bank noted that underlying inflation had reached the target level for the first time since the goal was set in 2013. Reuters reported at the time that this signified “victory” in a nearly 14-year battle against deflation, with policy now entering a more hawkish stage, making quarter-on-quarter rate hikes an option going forward.
Governor Kazuo Ueda reiterated this stance in parliament this week: the central bank is prepared to continue raising rates to ensure underlying inflation is anchored near 2%; he warned that core CPI growth could significantly exceed 2%—corporates are passing on labor costs, oil prices remain high, the yen stays weak, and global demand driven by AI construction fervor are all injecting extra momentum into inflation.
Upstream signals appeared earlier: in October, the corporate goods price index rose 7.1% year-on-year, above the 6.5% median forecast, with higher energy and industrial materials costs steadily passing downstream.
86% Probability of Rate Hike in December
As of press time, swap contracts show market pricing assigns about an 86% probability to a Bank of Japan rate hike on December 18. A survey of 71 economists from November 11 to 18 indicates 61 (86%) expect the central bank to hike in December—if realized, this would be the first time in 37 years there were three hikes in a single calendar year; of those predicting a hike, nearly 60% think policy rates will be raised another 25 basis points to 1.75% by the end of March next year. The current policy rate stands at 1.25%, the highest since 1995.
Rice Price Drop Masks Broader Price Pressures
Service prices—a key measure of inflation sustainability—rose 1.4% year-on-year. Food price growth, excluding fresh food, slowed to 2.2%, as rice prices fell by nearly 30% year-on-year, the largest drop since data began in 1971; just a year ago, rice was a major driver of overall inflation. The sharp drop in rice prices is actually due to the base effect of last year’s high levels: Tokyo’s October leading indicator shows rice prices fell 31.3%, mainly due to surplus inventories and low new rice prices.
Dai-ichi Life Research Institute believes the apparent slowdown is mainly due to fading special factors—rice prices and the misaligned year-on-year comparison for utility rates dragged the readings lower, but the underlying uptrend continues. They also warn that core inflation could surpass 3% by early 2027. Mizuho Securities market economist Ryosuke Katagi previously pointed out that, affected by the Middle East situation, prices for non-rice foods and daily necessities are expected to maintain strong momentum.
Corporate Pass-Through and Wage Increases for Workers
Corporations have been flexibly responding to rising business costs across energy, transportation, and packaging—a result of the Iran conflict and strong dollar combined with a weak yen. Labor shortages are also forcing firms to raise wages to retain staff. According to Teikoku Databank statistics, major Japanese food and beverage companies plan to raise prices on 1,477 products this month—nearly ten times last year’s figure.
However, while the case for rate hikes is firming, there are also evident constraints. Data from the Cabinet Office released on November 16 shows Japan’s real GDP shrank at an annualized rate of 0.1% in Q3, the first negative growth in four quarters, with private consumption down 0.3% quarter-on-quarter for the second consecutive negative quarter—Ueda noted the consumption decline was within the central bank’s expectations, mainly due to rising living costs and bad weather, and expects consumption to recover moderately.
There are also divisions within the central bank: two committee members voted against the rate hike decision in September, and dovish member Uniichiro Asada, nominated by Prime Minister Sanae Takaichi, has recently expressed caution over the pace of hikes; at the October meeting where rates were kept steady, hawkish member Hajime Takata proposed a straight hike to 1.5%, but was unsuccessful. A bill currently under parliamentary review to reduce consumption tax could statistically lower consumer prices by about 1.3 percentage points—meaning in the coming months, readings may diverge from the trajectory of core inflation, adding another decision-making challenge for the “data-dependent” Bank of Japan.
“The Bank of Japan’s policy focus has shifted from ‘escaping deflation’ to ‘preventing excessive inflation,’” commented Kazutaka Maeda, Senior Economist at Meiji Yasuda Research Institute, after the October meeting. “Rather than sticking to the previous assumption of a hike every six months, the central bank may now consider raising rates every three months, with the December meeting being a credible window for the next hike.”
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic surged at market opening, everything seemed perfect! Then the situation suddenly changed, US stocks plunged—what happened?
On Thursday, Anthropic's largest-ever IPO debuted on the market, surging over 38% at the open, giving the appearance of a strong endorsement for AI trading. However, this celebration was short-lived—U.S. stocks opened high but closed lower throughout the day, with the S&P 500 ending down 2% and the Nasdaq falling 2.25%. Short-selling attacks on AMD, IPOs worth over $100 billion draining liquidity, and negative Gamma positions reaching five-year highs—all contributed to the AI feast turning into a stress test for the U.S. stock market.
Anthropic's "super IPO": Over half of institutional investors didn't get a single share, while retail investors traded aggressively
More than 1,200 institutions competed to purchase Anthropic's IPO, with over half leaving empty-handed and almost all European investors missing out. Retail investors set a historical record for IPO trading volume since 2012, with a total transaction amount of $700-800 million, but this involved two-way trading rather than unilateral buying.
US bank stocks sound the alarm! AI impact and the shadow of interest rate hikes loom, "death cross" reappears, indicating a possible prolonged decline
After experiencing their worst four-day losing streak since April 2025, major U.S. bank stocks have fallen into a "Death Cross" technical pattern, signaling bearish momentum.
Potentially the Biggest Deal in the Biopharmaceutical Industry in Recent Years! Sanofi (SNY.US) Plans Major Acquisition; Insmed (INSM.US) Stock Surges Over 20%!
According to informed sources, Sanofi is evaluating the possibility of acquiring the American pharmaceutical company Insmed. With the appointment of a new CEO, the French pharmaceutical company is actively seeking its next blockbuster drug.
